News
Curium Partners with Oncidium Foundation to Support Access to Radioligand Therapy
11th May 2026
Moving on from Mallinckrodt: Curium eyes $650 million in radiopharmaceuticals sales
Curium North American CEO Dan Brague recently offered St. Louis Business Journal an insight into Curium journey, the state of nuclear medicine and the company’s vision for the future.
